News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
250,733 Results
Type
Article (7687)
Company Profile (15)
Press Release (243029)
Multimedia
Podcasts (12)
Webinars (3)
Section
Business (74967)
Career Advice (315)
Deals (14833)
Drug Delivery (47)
Drug Development (37024)
Employer Resources (24)
FDA (6535)
Job Trends (4947)
News (122545)
Policy (11711)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
Academia (619)
Accelerated approval (35)
ADA (14)
Adcomms (12)
Allergies (102)
Alliances (14905)
ALS (115)
Alzheimer's disease (840)
Antibody-drug conjugate (ADC) (358)
Approvals (7059)
Artificial intelligence (337)
ASCO (181)
Autoimmune disease (261)
Automation (23)
Bankruptcy (150)
Belgium (5)
Best Places to Work (4623)
BIO (28)
Biologics (8)
BIOSECURE Act (2)
Biosimilars (97)
BioSpace Insights (42)
Biotechnology (19)
Bispecific (1)
Bladder cancer (160)
Brain cancer (59)
Breast cancer (401)
Cancer (3983)
Cardiovascular disease (259)
Career advice (288)
Career pathing (16)
CAR-T (252)
CDC (14)
CDMO (34)
Celiac Disease (3)
Cell therapy (575)
Cervical cancer (40)
Clinical research (35358)
Collaboration (996)
Commercialization (3)
Compensation (285)
Complete response letters (41)
COVID-19 (827)
CRISPR (52)
C-suite (577)
Cystic fibrosis (77)
Data (6077)
Decentralized trials (1)
Denatured (7)
Depression (97)
Dermatology (70)
Diabetes (271)
Diagnostics (2634)
Digital health (25)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (157)
Drug pricing (69)
Drug shortages (19)
Duchenne muscular dystrophy (168)
Earnings (37593)
Editorial (24)
Employer branding (1)
Employer resources (20)
Events (35488)
Executive appointments (451)
Eye disease (2)
FDA (9299)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (17)
Frontotemporal dementia (25)
Funding (830)
Gene editing (120)
Generative AI (29)
Gene therapy (382)
GLP-1 (348)
Government (1360)
Grass and pollen (2)
Guidances (316)
Healthcare (6302)
Hematology (111)
HIV (67)
Huntington's disease (24)
IgA nephropathy (83)
Immunology and inflammation (113)
Immuno-oncology (70)
Indications (147)
Infectious disease (1002)
Inflammatory bowel disease (115)
Inflation Reduction Act (6)
Influenza (58)
Intellectual property (232)
Interviews (48)
IPO (8142)
IRA (21)
Job creations (573)
Job search strategy (229)
JPM (12)
Kidney cancer (20)
Kidney disease (43)
Labor market (20)
Layoffs (54)
Leadership (12)
Legal (2116)
Licensing (13)
Liver cancer (61)
Longevity (15)
Lung cancer (539)
Lymphoma (323)
Machine learning (29)
Management (7)
Manufacturing (496)
Marketing (7)
MASH (136)
Medical affairs (2)
Medical device (4931)
Medtech (5059)
Mergers & acquisitions (7600)
Metabolic disorders (722)
mRNA (74)
Multiple sclerosis (121)
NASH (9)
Netherlands (2)
Neurodegenerative disease (199)
Neuropsychiatric disorders (53)
Neuroscience (1698)
NextGen: Class of 2026 (1524)
Non-profit (751)
Now hiring (2)
Obesity (293)
Opinion (136)
Ovarian cancer (187)
Pain (147)
Pancreatic cancer (265)
Parkinson's disease (173)
Partnered (14)
Patents (440)
Patient recruitment (571)
Patient selection (6)
Peanut (22)
People (15981)
Peptides (4)
Pharmaceutical (7)
Pharmacy benefit managers (11)
Phase 1 (11340)
Phase 2 (15588)
Phase 3 (11643)
Pipeline (7834)
Policy (94)
Postmarket research (796)
Preclinical (4179)
Press Release (9)
Prostate cancer (201)
Psychedelics (19)
Radiopharmaceuticals (175)
Rare diseases (649)
Real estate (1024)
Recruiting (8)
Regenerative medicine (4)
Regulatory (11630)
Reports (25)
Research institute (558)
Resumes & cover letters (41)
Rett syndrome (39)
RNA editing (10)
RSV (40)
Schizophrenia (107)
Series A (135)
Series B (103)
Service/supplier (1)
Sickle cell disease (65)
Special edition (2)
Spinal muscular atrophy (42)
Sponsored (21)
Startups (710)
Stomach cancer (6)
Substance use disorders (11)
Supply chain (49)
Tariffs (14)
The Weekly (4)
Vaccines (383)
Venture capital (33)
Weight loss (148)
Wet AMD (1)
Women's health (66)
Worklife (5)
Date
Last 7 days (271)
Last 30 days (1117)
Last 365 days (15845)
2026 (11728)
2025 (15087)
2024 (16956)
2023 (19142)
2022 (22293)
2021 (23697)
2020 (21842)
2019 (14520)
2018 (10682)
2017 (11499)
2016 (9572)
2015 (11762)
2014 (8126)
2013 (5893)
2012 (6061)
2011 (6771)
2010 (6225)
Location
Africa (194)
Alabama (44)
Alaska (2)
Arizona (109)
Arkansas (4)
Asia (18969)
Australia (5207)
California (8128)
Canada (2503)
China (885)
Colorado (317)
Connecticut (426)
Delaware (190)
Europe (31223)
Florida (1277)
Georgia (152)
Hawaii (1)
Idaho (7)
Illinois (610)
India (100)
Indiana (291)
Iowa (4)
Japan (375)
Kansas (35)
Kentucky (16)
Louisiana (21)
Maine (51)
Maryland (849)
Massachusetts (5397)
Michigan (141)
Minnesota (285)
Missouri (85)
Montana (12)
Nebraska (9)
Nevada (122)
New Hampshire (47)
New Jersey (2467)
New Mexico (7)
New York (2276)
North Carolina (837)
North Dakota (2)
Northern California (4192)
Ohio (177)
Oklahoma (4)
Oregon (11)
Pennsylvania (1502)
Puerto Rico (15)
Rhode Island (18)
South America (313)
South Carolina (63)
Southern California (3338)
Tennessee (107)
Texas (1311)
United States (27517)
Utah (198)
Vermont (1)
Virginia (214)
Washington D.C. (21)
Washington State (694)
West Virginia (2)
Wisconsin (33)
Wyoming (1)
250,733 Results for "immunobiology limited immbio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
August 18, 2026
·
3 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering
September 18, 2026
·
5 min read
Press Releases
Kazia Therapeutics Limited Announces Proposed Public Offering
August 27, 2026
·
6 min read
Press Releases
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
August 28, 2026
·
7 min read
Press Releases
POMDOCTOR LIMITED to Participate in H.C. Wainwright’s 28th Annual Global Investment Conference
September 10, 2026
·
3 min read
Press Releases
Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering
August 31, 2026
·
6 min read
Press Releases
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion
August 19, 2026
·
2 min read
Press Releases
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
August 31, 2026
·
14 min read
Press Releases
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
September 14, 2026
·
3 min read
Press Releases
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
September 16, 2026
·
4 min read
1 of 25,074
Next
